AMG National Trust Bank Boosts Stake in GE HealthCare Technologies Inc. $GEHC

AMG National Trust Bank lifted its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 103.2% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 26,910 shares of the company’s stock after acquiring an additional 13,670 shares during the period. AMG National Trust Bank’s holdings in GE HealthCare Technologies were worth $1,915,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in GEHC. Laurel Wealth Advisors LLC purchased a new stake in shares of GE HealthCare Technologies in the fourth quarter valued at $26,000. Optima Capital LLC purchased a new position in GE HealthCare Technologies during the fourth quarter worth about $27,000. Godfrey Financial Associates Inc. purchased a new position in GE HealthCare Technologies during the fourth quarter worth about $27,000. Montag A & Associates Inc. boosted its stake in GE HealthCare Technologies by 105.4% in the 4th quarter. Montag A & Associates Inc. now owns 341 shares of the company’s stock worth $28,000 after buying an additional 175 shares during the last quarter. Finally, Transamerica Financial Advisors LLC grew its holdings in GE HealthCare Technologies by 331.6% in the 4th quarter. Transamerica Financial Advisors LLC now owns 341 shares of the company’s stock valued at $28,000 after buying an additional 262 shares during the period. Hedge funds and other institutional investors own 82.06% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts recently commented on the stock. Piper Sandler dropped their price target on shares of GE HealthCare Technologies from $88.00 to $74.00 in a research report on Thursday, April 30th. Oppenheimer reiterated an “outperform” rating and issued a $85.00 price target on shares of GE HealthCare Technologies in a report on Thursday, April 30th. Barclays lowered their price objective on shares of GE HealthCare Technologies from $87.00 to $78.00 and set an “equal weight” rating for the company in a research note on Thursday, April 30th. Argus decreased their target price on GE HealthCare Technologies from $95.00 to $80.00 and set a “buy” rating for the company in a research report on Tuesday, May 19th. Finally, The Goldman Sachs Group reiterated a “neutral” rating on shares of GE HealthCare Technologies in a research note on Monday, June 8th. Ten investment analysts have rated the stock with a Buy rating and ten have given a Hold rating to the company. According to data from MarketBeat, GE HealthCare Technologies has a consensus rating of “Moderate Buy” and an average target price of $79.48.

GE HealthCare Technologies Stock Down 5.6%

Shares of NASDAQ:GEHC opened at $61.66 on Wednesday. The company’s fifty day moving average is $63.54 and its two-hundred day moving average is $72.29. The company has a debt-to-equity ratio of 0.95, a quick ratio of 0.95 and a current ratio of 1.22. GE HealthCare Technologies Inc. has a 1-year low of $58.75 and a 1-year high of $89.77. The stock has a market capitalization of $28.05 billion, a price-to-earnings ratio of 14.75, a price-to-earnings-growth ratio of 1.78 and a beta of 0.72.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its earnings results on Wednesday, April 29th. The company reported $0.99 EPS for the quarter, missing analysts’ consensus estimates of $1.07 by ($0.08). The company had revenue of $5.13 billion during the quarter, compared to analyst estimates of $5.04 billion. GE HealthCare Technologies had a net margin of 9.10% and a return on equity of 20.46%. The business’s revenue was up 7.4% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.01 earnings per share. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. Equities analysts anticipate that GE HealthCare Technologies Inc. will post 4.89 EPS for the current year.

GE HealthCare Technologies Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, August 14th. Shareholders of record on Friday, July 24th will be given a dividend of $0.035 per share. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.2%. The ex-dividend date is Friday, July 24th. GE HealthCare Technologies’s payout ratio is 3.35%.

Insider Activity at GE HealthCare Technologies

In other news, Director Kevin Lobo bought 10,000 shares of the company’s stock in a transaction that occurred on Friday, May 22nd. The shares were purchased at an average price of $64.18 per share, with a total value of $641,800.00. Following the completion of the acquisition, the director directly owned 14,363 shares in the company, valued at approximately $921,817.34. This trade represents a 229.20% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Peter J. Arduini purchased 4,169 shares of the company’s stock in a transaction on Thursday, April 30th. The stock was acquired at an average price of $59.92 per share, for a total transaction of $249,806.48. Following the completion of the transaction, the chief executive officer owned 259,424 shares of the company’s stock, valued at $15,544,686.08. This represents a 1.63% increase in their position. The disclosure for this purchase is available in the SEC filing. Insiders purchased 21,847 shares of company stock worth $1,361,355 in the last three months. Insiders own 0.36% of the company’s stock.

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.